SEI INVESTMENTS CO - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 184 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$125,619
-73.0%
11,358
-67.2%
0.00%
-100.0%
Q1 2023$464,638
-12.3%
34,597
-19.2%
0.00%0.0%
Q4 2022$529,597
-80.9%
42,813
-36.7%
0.00%
-87.5%
Q3 2020$2,769,000
-23.3%
67,609
-11.2%
0.01%
-27.3%
Q2 2020$3,611,000
+1194.3%
76,107
+1479.0%
0.01%
+1000.0%
Q1 2020$279,000
-76.6%
4,820
-49.8%
0.00%
-75.0%
Q4 2019$1,194,000
+116.3%
9,600
+10.4%
0.00%
+300.0%
Q3 2019$552,000
+11.1%
8,697
+33.7%
0.00%
-50.0%
Q2 2019$497,000
+34.3%
6,505
+85.6%
0.00%
+100.0%
Q1 2019$370,000
+825.0%
3,505
+639.5%
0.00%
Q4 2018$40,000
+100.0%
474
+185.5%
0.00%
Q3 2018$20,000
-68.3%
166
-77.7%
0.00%
Q2 2018$63,000
+53.7%
746
+10.7%
0.00%
Q1 2018$41,000
+20.6%
674
+15.6%
0.00%
Q4 2017$34,000
-12.8%
583
-12.7%
0.00%
Q3 2017$39,000
-53.0%
668
-2.2%
0.00%
Q2 2017$83,000
+144.1%
683
+125.4%
0.00%
Q1 2017$34,000
+183.3%
303
+185.8%
0.00%
Q4 2016$12,000
-25.0%
106
+14.0%
0.00%
Q3 2016$16,000
+166.7%
93
+102.2%
0.00%
Q2 2016$6,000
+100.0%
46
+91.7%
0.00%
Q1 2016$3,000
-92.1%
24
-90.7%
0.00%
Q4 2015$38,000
-89.8%
259
-88.5%
0.00%
-100.0%
Q3 2015$372,000
-57.9%
2,247
-38.6%
0.00%
-62.5%
Q2 2015$883,000
-61.5%
3,660
-55.0%
0.01%
-60.0%
Q1 2015$2,293,000
+246.4%
8,128
+91.6%
0.02%
+233.3%
Q4 2014$662,0004,2430.01%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders